Waldemar Kulikowski
Olsztyn, WN, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Journal: Annals of hematology
Published: March 24, 2021
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 27, 2017
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 14, 2016
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Journal: The Lancet. Haematology
Published: February 15, 2015
Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: May 06, 2014
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
Journal: American journal of therapeutics
Published: April 16, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026